235 related articles for article (PubMed ID: 7937975)
21. Reduction of RI alpha subunit of cAMP-dependent protein kinase expression induces growth inhibition of human mammary epithelial cells transformed by TGF-alpha, c-Ha-ras, and c-erbB-2 genes.
Ciardiello F; Tortora G; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR
Ann N Y Acad Sci; 1993 Nov; 698():102-7. PubMed ID: 7904135
[No Abstract] [Full Text] [Related]
22. Nanoparticulate systems for the delivery of antisense oligonucleotides.
Lambert G; Fattal E; Couvreur P
Adv Drug Deliv Rev; 2001 Mar; 47(1):99-112. PubMed ID: 11251248
[TBL] [Abstract][Full Text] [Related]
23. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.
Ledwith BJ; Manam S; Kraynak AR; Nichols WW; Bradley MO
Mol Cell Biol; 1990 Apr; 10(4):1545-55. PubMed ID: 1690847
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM
J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312
[TBL] [Abstract][Full Text] [Related]
25. Reversal of the malignant phenotype by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Tone T; Jiao L; Wang W; Yoshida E; Kashfinn BI; Shitara T; Wu AM; Moreno JG
Antisense Res Dev; 1992; 2(1):3-15. PubMed ID: 1422085
[TBL] [Abstract][Full Text] [Related]
26. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
Chang MY; Won SJ; Liu HS
J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
Yang D; Li T; Xu W
Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):26-8. PubMed ID: 7774440
[TBL] [Abstract][Full Text] [Related]
28. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by antisense oligodeoxynucleotides directed against K-ras.
Kawada M; Fukazawa H; Mizuno S; Uehara Y
Biochem Biophys Res Commun; 1997 Feb; 231(3):735-7. PubMed ID: 9070883
[TBL] [Abstract][Full Text] [Related]
30. Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis.
Sénamaud-Beaufort C; Leforestier E; Saison-Behmoaras TE
Oligonucleotides; 2003; 13(6):465-78. PubMed ID: 15025913
[TBL] [Abstract][Full Text] [Related]
31. Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.
Andreyev HJ; Ross PJ; Cunningham D; Clarke PA
Gut; 2001 Feb; 48(2):230-7. PubMed ID: 11156646
[TBL] [Abstract][Full Text] [Related]
32. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
[TBL] [Abstract][Full Text] [Related]
33. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
34. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
35. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
Hélène C
Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
[TBL] [Abstract][Full Text] [Related]
36. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
[TBL] [Abstract][Full Text] [Related]
37. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
38. Sequence specific inhibition of in vitro translation of mutated or normal ras p21.
Yu ZP; Chen DF; Black RJ; Blake K; Ts'o PO; Miller P; Chang EH
J Exp Pathol; 1989; 4(2):97-108. PubMed ID: 2671311
[TBL] [Abstract][Full Text] [Related]
39. Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells.
Daaka Y; Wickstrom E
Oncogene Res; 1990; 5(4):267-75. PubMed ID: 2204019
[TBL] [Abstract][Full Text] [Related]
40. ras-induced neoplastic transformation and sensitivity to tumor necrosis factor.
Fernandez A; Chen PW; Ananthaswamy HN
Anticancer Res; 1994; 14(6B):2649-52. PubMed ID: 7872696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
